Delivery Order SPE2DB22D2206-SPE2DB23FKQ80

Award Date 9/28/23
Potential Completion Date 9/29/23
Potential Value $56K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $10,301.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MYRBETRIQ ER 25 MG TABLET 90S, a pharmaceutical product, with a performance period through September 20, 2023. This contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA...
The federal contract award, with ID SPE2DB20D3303|SPE2DB24FY0Q4, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,235.40 firm fixed-price delivery order is for the supply of MYRBETRIQ ER 25 MG TABLET 90S, a pharmaceutical product, with a period of performance through October 6, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $15,839.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MYRBETRIQ ER 25 MG TABLET 90S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a performance period ending on July 19, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by...
This federal contract award, valued at $3,495.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MYRBETRIQ ER 25 MG TABLET 90S, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
This federal contract award, with an ID of SPE2DB20D2104|SPE2DB25FMJJJ, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of MYRBETRIQ ER 50 MG TABLET 90S, a pharmaceutical product, with a ceiling value of $3,798.92 and a completion date of February 21, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,838.02, is a Firm Fixed Price Delivery Order for the supply of the pharmaceutical product MYRBETRIQ ER 25 MG TABLET 90S. The contract has an ultimate completion date of June 26, 2024. This contract appears to be part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This federal contract award, with ID SPE2DB22D3301|SPE2DB24FZ1MB, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,275.81, is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. The contract is for the supply of MYRBETRIQ ER 25 MG TABLET 90S, a...
This federal contract award, with ID SPE2DB22D3009|SPE2DB25FAR48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,430.56 firm fixed-price delivery order contract is for the supply of MYRBETRIQ ER 50 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of February 18, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award, with ID SPE2DB22D1017|SPE2DB25FF1RH, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,736.47 Firm Fixed Price Delivery Order is for the supply of MYRBETRIQ ER 50 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of December 19, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award, valued at $2,636.02, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MYRBETRIQ ER 25 MG TABLET 30S, a medical product, with a completion date of January 8, 2025. This appears to be a firm fixed-price delivery order contract, with no set-aside requirements indicated. Amerisourcebergen holds a significant Indefinite Delivery...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB23FKQ80
    Delivery Order

This federal contract award, with an ID of SPE2DB22D2206|SPE2DB23FKQ80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $56,397.63, is for the delivery of MYRBETRIQ ER 25 MG TABLET 30S, a pharmaceutical product.

The contract has an ultimate completion date of September 29, 2023 and is a Firm Fixed Price Delivery Order. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp, the prime contractor, is a for-profit organization registered in the System for Award Management (SAM.gov) with extensive experience in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems.

The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/12/25, 10:35 AM